The Texas Heart Institute
Avatar

Use of Finerenone in Patients with Diabetes Who Have Kidney Disease

By The Texas Heart Institute FEATURING George Bakris
By The Texas Heart Institute FEATURING George Bakris
2,221 views
September 7, 2023
3 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
13:42
George Bakris

Current Status of Prevention and Treatment of Diabetic Nephropathy

13:43
Stanford Medicine

What's the Ideal Therapy for Obesity?

Feat. A. Yeoh
15:25
Javed Butler

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

31:46
ACC 2024 Insights

ACC 2024 Insights: Evolving Pharmacology for HFrEF vs. HFpFF - With …

Feat. M. Costanzo
23:28
Inderpreet Madahar

GLP-1/GIP Mechanisms and Clinical Insights

58:35
University of Colorado Department of Medicine

Updates in Nephrology

Feat. A. Jovanovich
22:01
Cleveland Clinic Endocrinology & Metabolism Institute

Diabetes Management in CKD: KDIGO 2022 Clinical Practice Update

Feat. L. Caramori
31:19
Scripps Health

Updates on ADA Standards of Care - 2022

Feat. A. Tsimikas, L. Vincent
09:38
George Bakris

Hyperkalemia in Chronic Kidney Disease

67:29
Philips

PAD and CLI State of the Art: What Is the Role of Telemedicine? How …

Feat. C. Lesar, C. Walker, S. Madassery, T. Yates
Practical Ways to Achieve Targets in Diabetes Care

Diabetes Complications: Q&A / Panel Discussion

Feat. T. Brusko, J. Buse, S. Garg, S. Nissen, M. Rewers
12:52
Scripps Health: 2020 Updates in Diabetes Management

Update on SGLT2i in Diabetic Kidney Disease: How Effective Are Canag…

Feat. K. Harper
27:10
Indranil Dasgupta

Hypertension Management in Patients With Diabetic Kidney Disease

24:05
15th Annual Orange County Symposium for Cardiovascular Disease Prevention

Pillars of Therapy for Prevention of CVD in CKD Patients – the Cardi…

Feat. C. Mende
12:07
ERA 2023 Insights

ERA 2023 Insights: Serendipity of SGLT2 Inhibition in Diabetes and N…

Feat. V. Godanci Kelmendi
33:11
Practical Ways to Achieve Targets in Diabetes Care

ATDC 2022 Diabetic Nephropathy: A Mechanistic Approach to Therapy

Feat. R. DeFronzo
39:01
Scripps Health

Obesity and Diabetes Pharmacotherapy: Are You Ready for GLP-1 Agonis…

Feat. S. Harris